rxstatShortages › Diclofenac

Diclofenac shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Diclofenac products are in shortage in Canada (5 of 34 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 18, 2026.
Products affected
5 / 34
In shortage since
Mar 27, 2023
Est. full return
Sep 18, 2026
Reports on file
125
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
JAMP DICLOFENAC
0.1% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02534525 · since Mar 12, 2026, est. end Sep 18, 2026 · Disruption of the manufacture of the drug.
Active shortage
DICLOFENAC
0.1% · SOLUTION · PHARMA STULLN INC.
DIN 02475065 · since Mar 9, 2026, est. end Jun 12, 2026 · Delay in shipping of the drug.
Active shortage
PMS-DICLOFENAC
1.5% · SOLUTION · PHARMASCIENCE INC
DIN 02356783 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MINT-DICLOFENAC
0.1% · SOLUTION · MINT PHARMACEUTICALS INC
DIN 02475197 · since Mar 27, 2023, est. end Dec 31, 2025 · Disruption of the manufacture of the drug.
Active shortage
MINT-DICLOFENAC
0.1% · SOLUTION · MINT PHARMACEUTICALS INC
DIN 02475197 · since Mar 27, 2023, est. end Dec 31, 2025 · Disruption of the manufacture of the drug.
Active shortage
APO-DICLOFENAC OPHTHALMIC
0.1% · SOLUTION · APOTEX INC
DIN 02441020 · since Jul 11, 2023, no end estimate · Disruption of the manufacture of the drug.
reversed
PENNSAID
1.5% · SOLUTION · KNIGHT THERAPEUTICS INC.
DIN 02247265
Resolved
APO-DICLO SR
75MG · TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02162814 · ended Feb 26, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-DICLO SR
100MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02091194 · ended Dec 18, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ-DICLOFENAC
50MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02261928 · ended Jan 12, 2026 · Requirements related to complying with good manufacturing practices.
Discontinued
VOLTAREN OPHTHA
0.1% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 01940414
Resolved
APO-DICLO SR
75MG · TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02162814 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Diclofenac is currently affected by 5 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, PHARMA STULLN INC., PHARMASCIENCE INC, MINT PHARMACEUTICALS INC and 1 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Diclofenac is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).

Recent changes

Common questions

When will Diclofenac be back in stock in Canada?

The latest manufacturer estimate is Sep 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Diclofenac in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiinflammatory agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.